Role of Interleukin-2 and Herpes Simplex Virus 1 in Central Nervous System Demyelination in Mice

被引:13
|
作者
Mott, Kevin R. [1 ]
Zandian, Mandana [1 ]
Allen, Sariah J. [1 ]
Ghiasi, Homayon [1 ]
机构
[1] Cedars Sinai Med Ctr, Dept Surg, Ctr Neurobiol & Vaccine Dev, Los Angeles, CA 90048 USA
关键词
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS PATIENTS; MYELIN BASIC-PROTEIN; CD8; T-CELLS; CEREBROSPINAL-FLUID; IFN-GAMMA; HUMAN HERPESVIRUS-6; RECEPTOR LEVELS; OPTIC NEURITIS; DNA VACCINES;
D O I
10.1128/JVI.02241-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have reported previously that ocular infection of different strains of mice with recombinant herpes simplex virus 1 (HSV-1) constitutively expressing interleukin-2 (IL-2) provokes central nervous system (CNS) demyelination and optic neuropathy, as determined by changes in visual evoked cortical potentials and pathological changes in the optic nerve and CNS, whereas recombinant viruses expressing IL-4, gamma interferon, IL-12p35, IL-12p40, or IL-12p70 do not induce this neuropathy. The goal of this study was to dissect the mechanism underlying the interplay between the immune system (elevation of IL-2) and an environmental factor (infection with HSV-1) that elicits this pathology. Similar results were obtained upon delivery of IL-2 into the mouse brain using osmotic minipumps or injection of mice with recombinant IL-2 protein, IL-2 DNA, or IL-2 synthetic peptides prior to infection with wild-type (wt) HSV-1 strains McKrae and KOS. The critical role of IL-2 is further supported by our data, indicating that a single mutation at position T27A in IL-2 completely blocks the HSV-1-induced pathology. This study shows a novel model of autoimmunity in which viral infection and enhanced IL-2 cause CNS demyelination.
引用
收藏
页码:12102 / 12109
页数:8
相关论文
共 50 条
  • [41] Herpes Simplex Virus Type 1 (HSV-1) Infection of the Central Nervous System (CNS): Resistance to Mortality Differs from Resistance to the Development CNS Demyelination
    Kastrukoff, Lorne F.
    Lau, Allen S.
    Thomas, Eva E.
    NEUROLOGY, 2011, 76 (09) : A599 - A599
  • [42] HERPES-SIMPLEX VIRUS-INFECTIONS OF THE CENTRAL-NERVOUS-SYSTEM - ENCEPHALITIS AND NEONATAL HERPES
    WHITLEY, RJ
    DRUGS, 1991, 42 (03) : 406 - 427
  • [43] Herpes simplex virus type 2 infections of the central nervous system: A retrospective study of 49 patients
    Omland, Lars Haukali
    Vestergaard, Bent Faber
    Wandall, Johan Heugh
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 40 (01) : 59 - 62
  • [44] Expression of entry receptor nectin-1 of herpes simplex virus 1 and/or herpes simplex virus 2 in normal and neoplastic human nervous system tissues
    Guzman, G.
    Oh, S.
    Shukla, D.
    Engelhard, H. H.
    Valyi-Nagy, T.
    ACTA VIROLOGICA, 2006, 50 (01) : 59 - 66
  • [45] VIRUS-INDUCED DEMYELINATION IN HERPES-SIMPLEX VIRUS-INFECTED MICE
    KRISTENSSON, K
    SVENNERHOLM, B
    VAHLNE, A
    NILHEDEN, E
    PERSSON, L
    LYCKE, E
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1982, 53 (02) : 205 - 216
  • [46] Both Cerebral and Hematopoietic Deficiencies in CCR2 Result in Uncontrolled Herpes Simplex Virus Infection of the Central Nervous System in Mice
    Menasria, Rafik
    Canivet, Coraline
    Piret, Jocelyne
    Gosselin, Jean
    Boivin, Guy
    PLOS ONE, 2016, 11 (12):
  • [47] CENTRAL-NERVOUS-SYSTEM AND GENITAL-INFECTION WITH REACTIVATION OF LATENT HERPES-SIMPLEX VIRUS TYPE-2 IN MICE
    MARTIN, JR
    REED, EV
    MICROBIAL PATHOGENESIS, 1986, 1 (02) : 181 - 189
  • [48] Persistence of infectious herpes simplex virus type 2 in the nervous system in mice after antiviral chemotherapy
    Thackray, AM
    Field, HJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) : 97 - 102
  • [49] Incidence of Herpes simplex Virus Infection in Patients with Acute Central Nervous System Infections
    Perez S, Kriss
    Porto-Espinoza, Leticia
    Mindiola, Raimy
    Callejas M, Diana
    Estevez, Jesus
    Moronta, Reyna
    KASMERA, 2010, 38 (02) : 147 - 156
  • [50] HERPES-SIMPLEX VIRUS AND THE NERVOUS-SYSTEM
    KENNEDY, PGE
    POSTGRADUATE MEDICAL JOURNAL, 1984, 60 (702) : 253 - 259